The global prevalence of metastatic colorectal cancer continues presenting formidable healthcare challenges that demand sophisticated therapeutic solutions addressing disease heterogeneity, patient complexity, and evolving treatment requirements. This aggressive malignancy's progression from localized to disseminated disease creates substantial clinical management demands while generating...